Skip to main content
Screener/Healthcare/Biotechnology

ELVN — Enliven Therapeutics, Inc.

NASDAQ
$48.52-0.05 (-0.10%)
Mid CapUnder $50HealthcareLow Beta
$14.79
$48.79
$47.62
$49.94
EPS (TTM)$-1.64
P/E Ratio-23.49
Dividend Yield—
Market Cap$2.75B
Volume1.46M
Prev Close$48.60
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$23.6M$-0.38——
Q4 '25$0-$29.7M$-0.45——
Q3 '25$0-$20.1M$-0.32——
Q2 '25$0-$25.3M$-0.49——
Q1 '25$0-$28.5M$-0.57——
Q4 '24$0-$23.2M$-0.46——
Q3 '24$0-$23.2M$-0.48——
Q2 '24$0-$19.9M$-0.41——
Get Your Daily Market Recap